Adenovital vectors with cell type specificity for mesenchymal cells

Details for Australian Patent Application No. 2002315947 (hide)

Owner Crucell Holland B.V.

Inventors Vogels, Ronald; Havenga, Menzo Jans Emco; Bout, Abraham

Agent Davies Collison Cave

Pub. Number AU-B-2002315947

PCT Number PCT/NL02/00443

PCT Pub. Number WO2003/004661

Priority 10/010,645 13.11.01 US; 60/303,734 07.07.01 US; 01202619.1 06.07.01 EP

Filing date 5 July 2002

Wipo publication date 21 January 2003

Acceptance publication date 6 September 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/28 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/235 (2006.01) Medicinal preparations containing antigens or antibodies - Adenoviridae

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 10/010,645 13.11.01 US; 60/303,734 07.07.01 US; 01202619.1 06.07.01 EP

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002315947

6 September 2007 Application Accepted

  Published as AU-B-2002315947

1 November 2007 Application for Amendment

  The nature of the amendment is: Amend the invention title to read Adenoviral vectors with cell type specificity for mesenchymal cells . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

24 January 2008 Standard Patent Sealed

14 February 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Adenoviral vectors with cell type specificity for mesenchymal cells

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002315948-APPARATUS FOR PREPARING PURE CARBON DIOXIDE (CO2) FROM A GASEOUS CARBON DIOXIDE CONTAINING PRODUCT

2002315946-METHOD AND APPARATUS FOR PROPAGATING PLANTS BY CUTTINGS AND/OR RAISING PLANTS, IN PARTICULAR ROSES